Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andrew M D, Wolf"'
Autor:
Robert J, Volk, Viola B, Leal, Lianne E, Jacobs, Andrew M D, Wolf, Durado D, Brooks, Richard C, Wender, Robert A, Smith
Publikováno v:
CA: a cancer journal for clinicians. 68(4)
Autor:
Andrew M D, Wolf, Elizabeth T H, Fontham, Timothy R, Church, Christopher R, Flowers, Carmen E, Guerra, Samuel J, LaMonte, Ruth, Etzioni, Matthew T, McKenna, Kevin C, Oeffinger, Ya-Chen Tina, Shih, Louise C, Walter, Kimberly S, Andrews, Otis W, Brawley, Durado, Brooks, Stacey A, Fedewa, Deana, Manassaram-Baptiste, Rebecca L, Siegel, Richard C, Wender, Robert A, Smith
Publikováno v:
CA: a cancer journal for clinicians. 68(4)
In the United States, colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults and the second leading cause of death from cancer. For this guideline update, the American Cancer Society (ACS) used an existing systematic evidence
Autor:
Ted A, Skolarus, Andrew M D, Wolf, Nicole L, Erb, Durado D, Brooks, Brian M, Rivers, Willie, Underwood, Andrew L, Salner, Michael J, Zelefsky, Jeanny B, Aragon-Ching, Susan F, Slovin, Daniela A, Wittmann, Michael A, Hoyt, Victoria J, Sinibaldi, Gerald, Chodak, Mandi L, Pratt-Chapman, Rebecca L, Cowens-Alvarado
Publikováno v:
CA: a cancer journal for clinicians. 64(4)
Prostate cancer survivors approach 2.8 million in number and represent 1 in 5 of all cancer survivors in the United States. While guidelines exist for timely treatment and surveillance for recurrent disease, there is limited availability of guideline
Autor:
Richard, Wender, Elizabeth T H, Fontham, Ermilo, Barrera, Graham A, Colditz, Timothy R, Church, David S, Ettinger, Ruth, Etzioni, Christopher R, Flowers, G Scott, Gazelle, Douglas K, Kelsey, Samuel J, LaMonte, James S, Michaelson, Kevin C, Oeffinger, Ya-Chen Tina, Shih, Daniel C, Sullivan, William, Travis, Louise, Walter, Andrew M D, Wolf, Otis W, Brawley, Robert A, Smith
Publikováno v:
CA: a cancer journal for clinicians. 63(2)
Findings from the National Cancer Institute’s National Lung Screening Trial established that lung cancer mortality in specific high-risk groups can be reduced by annual screening with low-dose computed tomography. These findings indicate that the a
Publikováno v:
Southern Medical Journal. 92:440-441